Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies
John J. Brewington, … , Lauren M. Strecker, John P. Clancy
John J. Brewington, … , Lauren M. Strecker, John P. Clancy
Published July 12, 2018
Citation Information: JCI Insight. 2018;3(13):e99385. https://doi.org/10.1172/jci.insight.99385.
View: Text | PDF
Resource and Technical Advance Pulmonology

Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies

  • Text
  • PDF
Abstract

Recent advances in the management of cystic fibrosis (CF) target underlying defects in the CF transmembrane conductance regulator (CFTR) protein, but efficacy analyses remain limited to specific genotype–based subgroups. Patient-derived model systems may therefore aid in expanding access to these drugs. Brushed human nasal epithelial cells (HNEs) are an attractive tissue source, but it remains unclear how faithfully they recapitulate human bronchial epithelial cell (HBE) CFTR activity. We examined this gap using paired, brushed HNE/HBE samples from pediatric CF subjects with a wide variety of CFTR mutations cultured at the air-liquid interface. Growth and structural characteristics for the two cell types were similar, including differentiation into mature respiratory epithelia. In electrophysiologic analysis, no correlation was identified between nasal and bronchial cultures in baseline resistance or epithelial sodium channel (ENaC) activity. Conversely, robust correlation was demonstrated between nasal and bronchial cultures in both stimulated and inhibited CFTR activity. There was close correlation in modulator-induced change in CFTR activity, and CFTR activity in both cell types correlated with in vivo sweat chloride measurements. These data confirm that brushed HNE cell cultures recapitulate the functional CFTR characteristics of HBEs with fidelity and are therefore an appropriate noninvasive HBE surrogate for individualized CFTR analysis.

Authors

John J. Brewington, Erin T. Filbrandt, F.J. LaRosa III, Jessica D. Moncivaiz, Alicia J. Ostmann, Lauren M. Strecker, John P. Clancy

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 Total
Citations: 2 5 8 11 16 10 3 2 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Elexacaftor/Tezacaftor/Ivacaftor Supports Treatment for CF with ΔI1023-V1024-CFTR
Huang Y, Gonzales Cordova JM, Penrod S, Bendy LL, Cheng PC, Sanders DB, Davis MD, Gaston B, Chmiel JF
International Journal of Molecular Sciences 2025
Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application
Rubin M, Artusi I, Cozza G
Frontiers in Pharmacology 2025
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.
Bacalhau M, Camargo M, Lopes-Pacheco M
Journal of Personalized Medicine 2024
A Fast Scoring of Human Primary Respiratory Epithelia Grown at Air–Liquid Interface (ALI) to Assess Epithelial Morphology in Research and Personalized Medicine Settings
Lutsch CT, Feng L, Gómez Hohn A, Brandt L, Tamm S, Janciauskiene S, Stanke F, Jonigk D, Dittrich AM, Braubach P
Journal of Personalized Medicine 2024
Cell Culture Differentiation and Proliferation Conditions Influence the In Vitro Regeneration of the Human Airway Epithelium
Redman E, Fierville M, Cavard A, Plaisant M, Arguel MJ, Ruiz Garcia S, McAndrew EM, Girard-Riboulleau C, Lebrigand K, Magnone V, Ponzio G, Gras D, Chanez P, Abelanet S, Barbry P, Marcet B, Zaragosi LE
American Journal of Respiratory Cell and Molecular Biology 2024
Investigation of CFTR Function in Human Nasal Epithelial Cells Informs Personalized Medicine.
Pion A, Kavanagh E, Joynt AT, Raraigh KS, Vanscoy L, Langfelder-Schwind E, McNamara J, Moore B, Patel S, Merlo K, Temme R, Capurro V, Pesce E, Merlo C, Pedemonte N, Cutting GR, Sharma N
American journal of respiratory cell and molecular biology 2024
Glypican-3 is a key tuner of the Hedgehog pathway in COPD
Petit LM, Saber Cherif L, Devilliers MA, Hatoum S, Ancel J, Delepine G, Durlach A, Dubernard X, Mérol JC, Ruaux C, Polette M, Deslée G, Perotin JM, Dormoy V
Heliyon 2024
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.
Salinas DB, Wee CP, Bailey B, Raraigh K, Conrad D
Annals of the American Thoracic Society 2023
Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and Research
Fawcett LK, Turgutoglu N, Allan KM, Belessis Y, Widger J, Jaffe A, Waters SA
Journal of Personalized Medicine 2023
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient
Allan KM, Astore MA, Kardia E, Wong SL, Fawcett LK, Bell JL, Visser S, Chen PC, Griffith R, Jaffe A, Sivam S, Vittorio O, Kuyucak S, Waters SA
Frontiers in Molecular Biosciences 2023
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier.
Lee RE, Reidel B, Nelson MR, Macdonald JK, Kesimer M, Randell SH
Advanced Drug Delivery Reviews 2023
Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells
Joynt AT, Kavanagh EW, Newby GA, Mitchell S, Eastman AC, Paul KC, Bowling AD, Osorio DL, Merlo CA, Patel SU, Raraigh KS, Liu DR, Sharma N, Cutting GR
2023
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Oliver KE, Carlon MS, Pedemonte N, Lopes-Pacheco M
Expert Opinion on Pharmacotherapy 2023
Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis.
Rodenburg LW, Metzemaekers M, van der Windt IS, Smits SMA, den Hertog-Oosterhoff LA, Kruisselbrink E, Brunsveld JE, Michel S, de Winter-de Groot KM, van der Ent CK, Stadhouders R, Beekman JM, Amatngalim GD
Scientific Reports 2023
Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Otter CJ, Fausto A, Tan LH, Weiss SR, Cohen NA
Journal of visualized experiments : JoVE 2023
CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor
Karen S Raraigh, Kathleen C Paul, Jennifer L. Goralski, Erin N Worthington, Anna V Faino, Stanley Sciortino, Yiting Wang, Melis A Aksit, Hua Ling, Derek L. Osorio, Frankline M Onchiri, Shivani U Patel, Christian A. Merlo, Kristina Montemayor, Ronald L Gibson, Natalie E West, Amita Thakerar, Robert J Bridges, David N. Sheppard, Neeraj Sharma, Garry Cutting
JCI Insight 2022
CFTR-mediated monocyte-macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons
Xi Zhang, Camille M. Moore, Laura D Harmacek, Joanne Domenico, Vittobai Rashika Rangaraj, Justin Ideozu, Jennifer R Knapp, Katherine J Woods, Stephanie Jump, Shuang Jia, Jeremy W Prokop, Russell Bowler, Martin J. Hessner, Erwin W. Gelfand, Hara Levy
JCI Insight 2022
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs
E Sondo, F Cresta, C Pastorino, V Tomati, V Capurro, E Pesce, M Lena, M Iacomino, A Baffico, D Coviello, T Bandiera, F Zara, L Galietta, R Bocciardi, C Castellani, N Pedemonte
International journal of molecular sciences 2022
A medium composition containing normal resting glucose that supports differentiation of primary human airway cells
R Morgan, C Manfredi, K Easley, L Watkins, W Hunt, S Goudy, E Sorscher, M Koval, S Molina
Scientific Reports 2022
Established and Novel Human Translational Models to Advance Cystic Fibrosis Research, Drug Discovery, and Optimize CFTR-Targeting Therapeutics
Cholon DM, Gentzsch M
Current Opinion in Pharmacology 2022
Small molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough
Rhianna E Lee, Catherine A Lewis, Lihua He, Emily C Bulik-Sullivan, Samuel Gallant, Teresa M Mascenik, Hong Dang, Deborah M Cholon, Martina Gentzsch, Lisa Morton, John T Minges, Jonathan W. Theile, Neil A. Castle, Michael Knowles, Adam J Kimple, Scott H. Randell
Journal of Clinical Investigation 2022
Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect
Wong SL, Awatade NT, Astore MA, Allan KM, Carnell MJ, Slapetova I, Chen PC, Setiadi J, Pandzic E, Fawcett LK, Widger JR, Whan RM, Griffith R, Ooi CY, Kuyucak S, Jaffe A, Waters SA
American journal of respiratory cell and molecular biology 2022
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
Silva IA, Laselva O, Lopes-Pacheco M
Journal of Personalized Medicine 2022
Quantifying Intracellular Viral Pathogen: Specimen Preparation, Visualization and Quantification of Multiple Immunofluorescent Signals in Fixed Human Airway Epithelium Cultured at Air-Liquid Interface.
Wong SL, Pandzic E, Kardia E, Allan KM, Whan RM, Waters SA
Journal of Personalized Medicine 2022
Organotypic sinonasal airway culture systems are predictive of the mucociliary phenotype produced by bronchial airway epithelial cells
Delhove J, Alawami M, Macowan M, Lester SE, Nguyen PT, Jersmann HP, Reynolds PN, Roscioli E
Scientific Reports 2022
Patient-derived cell models for personalized medicine approaches in cystic fibrosis.
Ramalho AS, Amato F, Gentzsch M
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2022
Gene therapy for cystic fibrosis: new tools for precision medicine
JA Lee, A Cho, EN Huang, Y Xu, H Quach, J Hu, AP Wong
Journal of Translational Medicine 2021
Air−Liquid Interface Cultures of the Healthy and Diseased Human Respiratory Tract: Promises, Challenges, and Future Directions
D Baldassi, B Gabold, OM Merkel
2021
Large pH oscillations promote host defense against human airways infection
D Kim, J Liao, NB Scales, C Martini, X Luan, A Abu-Arish, R Robert, Y Luo, GA McKay, D Nguyen, MA Tewfik, CD Poirier, E Matouk, JP Ianowski, S Frenkiel, JW Hanrahan
Journal of Experimental Medicine 2021
A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
JX Jiang, L Wellhauser, O Laselva, I Utkina, Z Bozoky, T Gunawardena, Z Ngan, S Xia, MD Paola, PD Eckford, F Ratjen, TJ Moraes, J Parkinson, AP Wong, CE Bear
Stem Cell Reports 2021
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis
DE Keegan, JJ Brewington
International journal of molecular sciences 2021
CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling
JD Anderson, Z Liu, LV Odom, L Kersh, JS Guimbellot
American journal of physiology. Lung cellular and molecular physiology 2021
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
M Calucho, S Gartner, P Barranco, P Fernández-Álvarez, RG Pérez, EF Tizzano
Scientific Reports 2021
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles
M Comegna, G Conte, AP Falanga, M Marzano, G Cernera, AM Lullo, F Amato, N Borbone, S DErrico, F Ungaro, I dAngelo, G Oliviero, G Castaldo
Scientific Reports 2021
Breathe—Your immune system is counting on it
NA McCarty
Journal of Experimental Medicine 2021
Personalized Medicine Based on Nasal Epithelial Cells: Comparative Studies with Rectal Biopsies and Intestinal Organoids
IA Silva, V Railean, A Duarte, MD Amaral
Journal of Personalized Medicine 2021
Impact of inhaled pollutants on response to viral infection in controlled exposures
ME Rebuli, SA Brocke, I Jaspers
Journal of Allergy and Clinical Immunology 2021
Partial Decellularized Scaffold Combined with Autologous Nasal Epithelial Cell Sheet for Tracheal Tissue Engineering
LH Dang, SH Hung, Y Tseng, LX Quang, NT Le, CL Fang, H Tseng
International journal of molecular sciences 2021
Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
MP Dumas, S Xia, CE Bear, F Ratjen
EBioMedicine 2021
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells
G Sette, SL Cicero, G Blaconà, S Pierandrei, SM Bruno, V Salvati, G Castelli, M Falchi, B Fabrizzi, G Cimino, RD Maria, M Biffoni, A Eramo, M Lucarelli
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2021
Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation
E Gecili, W Su, C Brokamp, E Andrinopoulou, F LaRosa, T Pestian, J Clancy, G Solomon, J Brewington, R Szczesniak
Journal of Cystic Fibrosis 2021
Culture and Imaging of Human Nasal Epithelial Organoids
Liu Z, Anderson JD, Natt J, Guimbellot JS
Journal of visualized experiments : JoVE 2021
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Guido Veit, Ariel Roldan, Mark A. Hancock, Dillon F. Da Fonte, Haijin Xu, Maytham Hussein, Saul Frenkiel, Elias Matouk, Tony Velkov, Gergely L. Lukacs
JCI Insight 2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
MD Kim, N Baumlin, JS Dennis, M Yoshida, A Kis, C Aguiar, A Schmid, E Mendes, M Salathe
ERJ Open Research 2020
Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD
R Belgacemi, E Luczka, J Ancel, Z Diabasana, JM Perotin, A Germain, N Lalun, P Birembaut, X Dubernard, JC Mérol, G Delepine, M Polette, G Deslée, V Dormoy
EBioMedicine 2020
The future of cystic fibrosis care: a global perspective
SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, E Tullis, C Castaños, C Castellani, CA Byrnes, F Cathcart, SH Chotirmall, R Cosgriff, I Eichler, I Fajac, CH Goss, P Drevinek, PM Farrell, AM Gravelle, T Havermans, N Mayer-Hamblett, N Kashirskaya, E Kerem, JL Mathew, EF McKone, L Naehrlich, SZ Nasr, GR Oates, C O'Neill, U Pypops, KS Raraigh, SM Rowe, KW Southern, S Sivam, AL Stephenson, M Zampoli, F Ratjen
The lancet. Respiratory medicine 2020
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
M Lopes-Pacheco
Frontiers in pharmacology 2020
Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
DR Laucirica, LW Garratt, A Kicic
Frontiers in immunology 2020
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
Z Liu, JD Anderson, L Deng, S Mackay, J Bailey, L Kersh, SM Rowe, JS Guimbellot
Genes & development 2020
Choice of Differentiation Media Significantly Impacts Cell Lineage and Response to CFTR Modulators in Fully Differentiated Primary Cultures of Cystic Fibrosis Human Airway Epithelial Cells
V Saint-Criq, L Delpiano, J Casement, JC Onuora, JH Lin, MA Gray
Cells 2020
Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models
JK Park, A Shrivastava, C Zhang, BA Pollok, WE Finkbeiner, ER Gibb, NP Ly, B Illek
Frontiers in Pediatrics 2020
In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells
RE Rayner, J Wellmerling, W Osman, S Honesty, M Alfaro, ME Peeples, E Cormet-Boyaka
Journal of Cystic Fibrosis 2020
Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis
M Mitroi, D Albulescu, A Capitanescu, A Docea, G Musat, G Mitroi, O Zlatian, A Tsatsakis, G Tzanakakis, D Spandidos, D Calina
Molecular medicine reports 2019
A marine-sourced fucoidan solution inhibits Toll-like-receptor-3-induced cytokine release by human bronchial epithelial cells
M Dutot, S Grassin-Delyle, H Salvator, M Brollo, P Rat, R Fagon, E Naline, P Devillier
International Journal of Biological Macromolecules 2019
Ciliated Epithelial Cell Differentiation at Air-Liquid Interface Using Commercially Available Culture Media
Dani Do Hyang Lee, Alina Petris, Robert E Hynds, Christopher O'Callaghan
Methods in molecular biology (Clifton, N.J.) 2019
Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
NT Awatade, SL Wong, CK Hewson, LK Fawcett, A Kicic, A Jaffe, SA Waters
Frontiers in pharmacology 2018
Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine
E Matthes, J Goepp, C Martini, J Shan, J Liao, DY Thomas, JW Hanrahan
Frontiers in pharmacology 2018

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts